Nabil Saba, MD, FACP
- Professor of Hematology & Medical Oncology and Otolaryngology, Emory University School of Medicine
- Director, Head and Neck Medical Oncology Program, Winship Cancer Institute of Emory University
Sponsored Research Projects
- An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- CA209-648: Phase 3 Study of CheckMate 648- Esophageal Squamous Cell Carcinoma
- CA209-651:Phase III Study of Nivolumab vs Extreme Study Regimen (SCCHN)
- D4193C00002: A Phase III Randomized, Open-Label, Multi-Center, Global Study of MED
Program Topics
Affiliated Units
- Emory University School of Medicine
- Winship Cancer Institute of Emory University